tirzepatide and yeast infections Do GLP-1 Medications Cause Infections? Facts Prevention First FDA-Approved Treatment for Chronic

Brad Stanfield is a New Zealand GP and clinical researcher who publicly disclosed in May 2026 that he takes 1.25 mg of tirzepatide weekly one quarter of the standard starting dose

While metformin decreases hepatic glucose production and improves insulin sensitivity, tirzepatide activates GLP-1 and GIP receptors to enhance insulin secretion and reduce appetite

Avoid repeated freezethaw cycles that may compromise peptide stability

PMID: 31942519

We find that patients benefit from at least a 12-month comprehensive weight-loss program to establish the proper habits to sustain long-term weight loss If you are not a good candidate for GLP-1 agonists, our physicians will offer different modalities of weight loss for you, including alternative medications, lifestyle modification, continuous glucose monitoring, and other tools that we use as a part of our weight loss program in El Cajon, California

I expect that number to grow a lot as time goes on